Product liability roundup
by Walter Olson on January 25, 2013
- The late John O’Quinn was an Overlawyered regular: “Ex-clients’ complaint vs silicosis lawyers is catalog of misconduct” [Alison Frankel, Reuters; Ted Frank, Point of Law]
- “How Lawsuits Killed an American Icon” [Rocky Flick, CEO, on closure of Blitz gas can plant in Oklahoma; U.S. Chamber's Faces of Lawsuit Abuse, auto-plays video; earlier here, here, here]
- “Angelos seeks to revive more than 13,000 asbestos cases” [Baltimore Sun] Virginia is latest state to wrestle with asbestos causation standard [David Oliver] Asbestos forum-shopping alive and well in Madison County, Ill., with record-breaking 1,563 cases filed last year [Chamber-backed Madison County Record]
- More on why Toyota settled dubious acceleration case [Michael Krauss, earlier]
- Alabama rules brand-name drug manufacturer can be held liable for generic version’s lack of a warning [Weeks v. Wyeth; Meghan McCaffrey, Weil Gotshal Product Liability Monitor; Morrison Foerster client alert; Michael Krauss] Standards of causation in pharmaceutical cases haven’t been loosened as far as in asbestos [Beck, Drug & Device Law]
- From Judge Gladys Kessler, another sweeping ruling against tobacco companies [Brian Wolfman, CL&P]
- In the coming era of driverless cars, better to empower a robotic “intersection controller,” or rely on intelligence distributed among the individual vehicles? [Mickey Kaus, Jack Baruth/Truth About Cars, E.W. Niedermeyer first, second]
Tagged as:
Alabama,
asbestos,
John O'Quinn,
pharmaceuticals,
silicosis,
tobacco,
Toyota,
traffic laws,
Virginia
{ 1 trackback }
Comments on this entry are closed.